about
Seizure prophylaxis in neurocritical care: a review of evidence-based support.Thromboelastographic changes in patients experiencing an acute ischemic stroke and receiving alteplase.Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage.Evaluation of the Hemodynamic Effects of Intravenous Amiodarone Formulations During the Maintenance Phase Infusion.Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit.Use of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration.Key articles and guidelines in the primary prevention of ischemic stroke.Management of apixaban-associated subdural hematoma: a case report on the use of factor eight inhibitor bypassing activity.Analysis of anticoagulation reversal survey (ARES)
P50
Q38166331-A129745E-6EFB-4239-B7DB-6D78A789A619Q38179580-8C8F4C37-4AE4-4092-974F-FE9FB9356E44Q39898890-6AA6B9DD-337B-4A09-8405-3FFBF83CB1C7Q40488694-174AB5CB-EAC2-4FFB-81AE-E67256859835Q40526351-9381B3CE-80D8-4EED-B0CF-7CDA5F8AAC12Q43151775-18E73D2B-6608-4A92-9C06-980C8733E1C5Q45256406-FBC658B6-DB8F-41D1-B398-7640C5788FFDQ50595181-191A6EF0-746C-4484-B297-66A42EE3E3B7Q91965983-41B8228F-E101-4D3C-B75D-721AE1F94C7E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
A Shaun Rowe
@en
A Shaun Rowe
@nl
type
label
A Shaun Rowe
@en
A Shaun Rowe
@nl
prefLabel
A Shaun Rowe
@en
A Shaun Rowe
@nl
P31
P496
0000-0002-2533-9233